A Chinese family with cat eye syndrome and abnormality of eye movement: First case report.

1.35 mb tetrasomy abnormality of eye movement cat eye syndrome (CES) early diagnosis first report

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2023
Historique:
received: 25 01 2023
accepted: 20 03 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Cat eye syndrome (CES) is a rare disease with a wide spectrum of phenotypic variability that is observed in 1:150,000 newborns. CES is characterized clinically by the combination of iris coloboma, anal atresia, and preauricular tags and/or pits. Many eye malformations have been reported to be associated with CES, such as iris and chorioretinal coloboma. However, an abnormality of eye movement has not been previously reported. We report on a Chinese family carrying a 22q11.1-q11.21 duplication of 1.7Mb tetrasomy (chr22:16,500,000-18,200,000, hg38) in two generations. Based on the proband and her father's clinical manifestations, including ophthalmological examination, cytogenetic analysis, FISH, CNV-seq, and WES, the diagnosis of CES with an abnormality of eye movement was made. Our findings broadened the symptom spectrum of CES syndrome and laid the foundation for pathogenesis, diagnostic targets, and drug research on the abnormality of eye movement, and were helpful for early diagnosis and intervention of CES.

Sections du résumé

Background UNASSIGNED
Cat eye syndrome (CES) is a rare disease with a wide spectrum of phenotypic variability that is observed in 1:150,000 newborns. CES is characterized clinically by the combination of iris coloboma, anal atresia, and preauricular tags and/or pits. Many eye malformations have been reported to be associated with CES, such as iris and chorioretinal coloboma. However, an abnormality of eye movement has not been previously reported.
Case presentation UNASSIGNED
We report on a Chinese family carrying a 22q11.1-q11.21 duplication of 1.7Mb tetrasomy (chr22:16,500,000-18,200,000, hg38) in two generations. Based on the proband and her father's clinical manifestations, including ophthalmological examination, cytogenetic analysis, FISH, CNV-seq, and WES, the diagnosis of CES with an abnormality of eye movement was made.
Conclusion UNASSIGNED
Our findings broadened the symptom spectrum of CES syndrome and laid the foundation for pathogenesis, diagnostic targets, and drug research on the abnormality of eye movement, and were helpful for early diagnosis and intervention of CES.

Identifiants

pubmed: 37114001
doi: 10.3389/fped.2023.1145183
pmc: PMC10126520
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1145183

Informations de copyright

© 2023 Lu, Shen, Zheng, Zhang, Liu, Qi, Huang and Shen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Dev Biol. 2018 Dec 1;444 Suppl 1:S79-S97
pubmed: 29453943
Front Genet. 2021 Jul 15;12:706641
pubmed: 34335701
Eye (Lond). 2007 Feb;21(2):289-91
pubmed: 17001329
Neural Dev. 2007 Oct 30;2:21
pubmed: 17971221
Curr Opin Ophthalmol. 2019 Sep;30(5):314-318
pubmed: 31313749
Am J Hum Genet. 1999 Dec;65(6):1639-46
pubmed: 10577917
Lancet. 1965 Aug 7;2(7406):290
pubmed: 14330081
Am J Hum Genet. 2002 May;70(5):1077-88
pubmed: 11925570
Genome Res. 2019 Sep;29(9):1389-1401
pubmed: 31481461
Am J Med Genet A. 2012 May;158A(5):1111-7
pubmed: 22495764
Am J Med Genet A. 2020 Nov;182(11):2624-2631
pubmed: 32893956
Clin Genet. 1985 Dec;28(6):509-15
pubmed: 3865751
Eur J Med Genet. 2009 Mar-Jun;52(2-3):88-93
pubmed: 19254783
Ophthalmology. 2014 Jan;121(1):392-398
pubmed: 23972321

Auteurs

Yang Lu (Y)

Health Clinic Center for Enze Precision Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

Liping Shen (L)

Health Clinic Center for Enze Precision Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

Yue Zheng (Y)

Department of Ophthalmology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

Haichen Zhang (H)

Department of Endocrinology, Peking Union Medical College Hospital, Beijing, China.

Yanbo Liu (Y)

Clinical Genome Center, DIAN Diagnostics, Hangzhou, China.

Ming Qi (M)

Clinical Genome Center, DIAN Diagnostics, Hangzhou, China.
Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, USA.

Shangzhi Huang (S)

Department of Medical Genetics, Peking Union Medical College, Beijing, China.

Bo Shen (B)

Health Clinic Center for Enze Precision Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

Classifications MeSH